<<

1/3/18

Believe It...or Not! Disclosures A Peek Behind the Curtain at the Future of Care • No financial interest in any product discussed • Some past lecturing and/or paid research for Alcon,

Allergan, Bausch & Lomb/Valeant, Pfizer, & Inspire • Mention of these products in no way implies endorsement by the presenter

• (mention of these products in no way implies expertise on Chris Wroten, O.D. behalf of the presenter either!) [email protected]

Believe It or Not...

• Alternative Health Care Technologies • Contact Alternave Healthcare Technologies • Traditional Technology Advances • Non-Traditional Healthcare Delivery • Scope of Practice/Scope of Payment Contact Lenses... • Registries • Medicare Payment Reform • Implantable Technologies • Surgery Advances • Management Options • Lesion Removal & Cosmetic Therapies • Miscellaneous Therapeutic Advances

NaturalVue from Visioneering Technologies 3-D Prinng • Richard Griffin, O.D. Ophthalmic applicaons • NEI Grant to develop • Contact Lenses? • 14 patents • So, daily disposable mulfocal, etafilcon A • “Neurofocus Opcs” • Center distance, extended depth of focus design • Single add power • progression control?...regression?!?!

1 1/3/18

Triggerfish (Sensimed) Hyper-CL (EyeYon Medical)

FDA-approved in U.S. March 2016 • Israeli Company Connuous IOP-monitoring from silicone CL • Hyperosmoc CL to treat K edema (with hypertonic g) • FDA-approved 2016

Telescopic Contact Lenses (for AMD)

• Swiss Researchers (Defense Advanced Research Projects Agency) • Contains miniscule mirrors arranged to mimic Galilean telescope, acng like built-in binoculars; can be paired with receiving specs • Challenge is thickness (1.55mm vs normal 0.35mm) Courtesy: cnn.com Also adjustable focus MF CL, too?

Night Vision Contacts?!?! Alternave Health Care Technologies

“Tradional” Technology Advances

2 1/3/18

Adjustable Focus : Adlens Focuss Kinec The image cannot be displayed. Your computer may not have enough memory to open the image, or the image The image cannot be displayed. Your computer may not have enough memory to open the image, or the image mayThe imagehave been cannot corrupted. be displayed. Restart Your your computer computer, may and not then have open enough the file memory again. to If the red x still appears, you may may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may haveopen tothe delete image, the or image the image and thenmay inserthave been it again. corrupted. Restart your computer, and have to delete the image and then insert it again. Adjustable Focus Glasses: Thethen image open thecannot file again.be displayed.The If imagethe red Your cannot x still computer beappears, displayed. may you not mayYour have have computer enough to delete memorymay the not image tohave open the image, or the image and then insert it again.enough memory to open the image, or the image may have been Themay imagehave been cannot corrupted. be displayed. Restart Your your computer computer, may and not then have open enough the file memory again. to If openthe red the x image,still appears, or the youimage may have to delete the imagecorrupted. and then Restart insert ityour again. computer, and then open the file again. If Trufocals/Superfocus, Empower, Adlens may have been corrupted.the redRestart x still your appears, computer, you mayand havethen opento delete the filethe again.image Ifand the then red x still appears, you may have to delete the imageinsert and it then again. insert it again.

Horus • Similar product • Assesses paent's visual needs & facial features • Advanced soware calculates ideal posion in relaon to the , then designs frame based on those unique parameters • 3D prinng allows further customizaon of the frame according to paent’s visual, comfort & aesthec needs

Other “Smart” Specs...

Will wearable technology also change the way we • Carl Zeiss SmartOpcs correct refracve disorders & interact with the world?

• Google Glass • Mad Glass • Senth IN1 • Sound Glasses • iGlass? • others

3 1/3/18

Other “Smart” Specs... OAKLEY

• CTRL Eyewear • Oakley Prizm Lenses • Polarized • Color-opmized (Green=Golf, Blue=Fishing, etc.) • Oakley Radar Pace • $495 • AI Sunglasses • Biometrics + “Coach”

Other “Smart” Specs... Project Blaid (Toyota)

• Amblyz (XPAND)- digital LCD • Wearable device that scans the “patch” glasses environment • Programmable • Uses cameras & recognion soware • “Good” eye lens alternates • Will integrate: clear to opaque x 30 secs • Mapping • Study of 33 kids, age 3-8 yrs • Object ID (doors, Exit signs, stairs, with moderate amblyopia escalator, restroom signs, etc.) (20/40-20/100): 4 hrs of • Facial recognion technologies Amlbyz = 2 hrs patching • Users can request locaon of certain things & feedback audibly or by vibraon

Proximity Hat MyEye (OrCam)

• For visually impaired & those in poor lighng condions • Already successfully tested in Germany • Scans environment 50 x’s/sec • Applies pressure to wearer’s head in direcon of obstacle

4 1/3/18

Horus

• Samsung • Lan “return back to the light” • Uses image processing • Modes: • Regular (enhances outlines) • Color Invert • Paral Vision • Relocator • Tunnel Vision • Display Color Filter

Digital Vision Opmizer (DigitalVision Systems) Digital Vision Opmizer (DigitalVision Systems) • Virtual refracng plaorm to dx vision disorders & procure customized, digital, free-form lenses/glasses • Paents interacvely choose & opmize design of their correcve lenses under natural, real-world viewing condions • Provides “beer vision and viewing comfort than convenonal eyewear procured using error-prone phoropter measurements” • Vision tesng & fing info xmied to lab • Partners: , Zeiss, Hoya, Transions, Ga. Tech, others

3-D Prinng: Surgical Applicaons?

Alternave Health Care Technologies Australian Co. Anatomics/Lab 22 @ CSIRO Non-Tradional Technology Advances 3-D printed Ti sternum/rib cage successfully implanted in cancer paent in Spain

5 1/3/18

3-D Prinng: Surgical Applicaons? 3-D Prinng: Surgical Applicaons?

Wake Forest Bapst Medical Center: • EpiBone Integrated Tissue & Organ Prinng System (ITOP) • Employs 3-D bioprinng to produce living human ssues & bone

3-D Prinng: Surgical Applicaons? 3-D Prinng: Surgical Applicaons?

Corneal Confocal Microscopy (CCM)

• Examines unmyelinated corneal nerve fibers @ high mag, using Lens Autofluorescence laser-scanning CCM to image corneal sub-basal nerve plexus New possible • Using Lens Fluorescence Biomicroscope calibrated with standards indicaon for • Predicts insipient peripheral neuropathy in Type 1 DM traceable to Naonal Instute of Standards and Technology (NIST): diagnosing MS (63% Sensive; 74% Specific) • Type 2 DM Detecon (via AGEs on lens) • Reduced Corneal NFL length & Corneal sensivity = increased • Sensivity = 67%, Specificity = 94% severity diabec peripheral neuropathy (Hemoglobin A1C: Sens.= 44%, Spec.= 79%) • Previous studies demonstrate ulity for CCM in other neuropathies (Fasng Plasma Gluc.: Sens.=50%, Spec.= 95%) • Takes 6 secs, non-invasive, doesn’t require fasng

6 1/3/18

Lens Autofluorescence my Vision Track (a.k.a. mVT) from Vital Art and Science • FDA-approved • Rx only, free download* • Home monitor • AMD & DR

*Charge to share FDA Market Clearance 2013 data with doctor

Epigenecs... 23andME • FDA-approved • Direct-to-consumer genotyping • 36 condions currently(Sjogren’s, Sickle Cell) • ?, AMD?, RP?, Color Deficiency? • Salivary sample

7 1/3/18

Color Vision Deficiency...

Color Vision Deficiency

• App-based products • Diagnosc? • Daily use...

enchroma

8 1/3/18

Red-Green

Colorblind Cure.flv - YouTube

New Test for Color Blindness Regenerave Medicine: Stem Cells

• Shinya Yamanaka (Japan) • 2006 discovered pluripotent stem cells (iPSCs) • Nobel Prize • Allows sciensts to regenerate any type of cell into an embryonic cell • Companies now developing treatments to “replace damaged ” (expected to launch in Japan in 2018) & AMD...who?

9 1/3/18

Stem Cells: Ocata Therapeucs/Astellas Stem Cells: Ocata Therapeucs/Astellas

Skin-to-Eye Stem Cells Transplant? Sept. 2014 • Luxturna (voregene neparvovec-ryzl) Yasuo Kiromoto, M.D., Ph.D, @ Kobe City Medical Center Gen. Hosp. st • Gene therapy for inherited renal dystrophies Performed 1 -ever human skin cell xplant in 70-yr old Japanese female • Succeeded in late-stage clinical trial • Paent’s skin cells used to generate induced Pluripotent Stem Cells • 1st gene therapy for genec disorders to win FDA approval in U.S. (iPSCs) (Dec. ‘17) • iPSCs then used to create Renal Pigment Epithelium (RPE) sheet • 2 gene therapies for cancer have also been approved • RPE sheet then implanted in paent’s eye • Cost? • 1 year later: no rejecon & subjecve improvement in sight

Skin-to-Eye Stem Cells Transplant? Stem Cells...for !?!?

03/09/16 Journal Nature: Sep. 2016: Another team at Japan’s RIKEN Center for Developmental Biology... “Stem Cells were Successfully Used To Treat Congenital Cataracts In 12 Babies” • Used major histocompability complex (MHC) matching to grow RPE cells from induced pluripotent stem cells (iPSCs) in skin cells with no • Univ. California-San Diego sciensts, in conjuncon with Shiley Eye Instute & rejecon researchers in China, used stem cells &... • • Reported the infants “regrew lenses” that are “funconal and appear to act Could allow “RPE banks” normally in the infants, who are now toddlers”

10 1/3/18

• Kiosks? Alternave Health Care Delivery Models • Telemedicine

Arficial Intelligence in Eye Care?...

Google’s IBM Watson

• Google’s Arficial Intelligence Computer Program • IBM Researchers in Australia have trained Watson to detect abnormalies (e.g. • Taught itself how to play 49 different video games with only raw pixel input AMD, diabec renopathy, & glaucoma) in renal photographs • Plans to use >1M anonymized eye scans to “teach computers how to • Able to measure C/D & determine signs of glaucoma with up to 95% accuracy diagnose

11 1/3/18

App-Based Technologies...

Opternave Simple Contacts 20/20 Now

Evolving Trends in Eye Care

Scope of Pracce Needs

12 1/3/18

Physician Extenders/Replacers? • Rena study...can nurses safely administer intra-vitreal injecons?

Disposable Intravitreal Injecon Speculum

Physician Extenders/Replacers? • Nurses provided 3,355 hospital- based intravitreal injecons • No complaints from paents • Only 0.3% minor adverse events (subconj. heme & k abrasion) • Conclusion: Appropriately trained non-medical staff can improve efficiency & access

New & Emerging Ocular Technology PRO-IOP (Implandata Ophthalmic Products)

• Implantable Microsensor Implantable Technology • Capable of Measuring Absolute IOP connuously or on-demand • Sends data via GSM/modem to Paent & Doctor with IOP ALERT

13 1/3/18

Implantable Telescope: CentraSight Implandata Ophthalmic Products “PRO-IOP”

Iris II Epirenal Implant (Pixium Vision) Argus II Renal Prosthesis System (Second Sight)

• For advanced RP paents • CE Mark & FDA-approved for advanced RP • 150 mini-electrodes • Implanted in worse-seeing eye • CE Mark applied for

Orion I: Visual Corcal Prosthesis (Second Sight)

• Wireless, Mulitchannel Neurosmulaon System ( New & Emerging Ocular Technology Smulator) • First implantaon & acvaon in human subject completed • UCLA – successful proof of concept & IOLs • 30 yr old blind paent • Could perceive & localize light with no adverse effects (4 million procedures in U.S. in 2015) • Inial FDA applicaon pending

14 1/3/18

MKO Melt

Verion Image-Guided Cataract Surgery Suite (Alcon) Conscious Sedaon (Imprimis)

• Novel proprietary formulaon (midazolam-ketamine-ondansetron) • Sedaon + anesthesia/analgesia • Can be used in place of IV sedaon for cat sx in 85% of paents • Specifically for ophthalmic use (as well as other procedures) • 2-pack=$25 (usually only need 1) • Sublingual • Available as of 2016

Drop Compliance ReSure (Ocular Therapeux) • >90% of paents non-compliant with ocular meds (from glaucoma studies; & • Hydrogel corneal wound sealant with blue visualizaon aid ~50% stop taking glaucoma meds before 6 mos of therapy ends) • Indicaon for Cataract Surgery Incision Closure (& others?) • 41% of those admit challenges in paying for their meds • Applied to dried x 20 secs; study = signif. beer than suture • 1 in 4 glaucoma paents admits to missing at least one drop per week

Dropless Cataract Surgery (www.godropless.com) “Less Drops” Cataract Surgery Intracameral Trans-zonular • 3 ml = $30.00 Tri-Mox • 6 ml = $60.00 3x ê CME 3x ê Endophthalmis (22x êwith Cephalosporin!)

15 1/3/18

B&L Trulign Toric

Tecnis Symfony (Abbo Medical Opcs) • Only “accommodave” toric IOL approved in U.S. (toric Crystalens) • Reportedly good distance & intermediate vision • Some post-op surprises?

FDA Approval July 2016; CE Mark 2014 No glare/halos (corrects chromac aberraon) Monofocal-like DVA?

Lenstec Tetraflex SmartIOL (Medennium)

• CE Mark received • “Accommodave” IOL • More stable post-op refracon than Crystalens?

Thermodynamic hydrophobic acrylic; Pre-Clinical Trials

IC-8 (AcuFocus)

LiquiLens IOL (Vision Soluon Technologies)

Contains 2 immiscible fluids & relies on agravity-dependent juxtaposion in downward gaze to add power in visual axis

Alan Glazier, O.D.

In Clinical Trials

Approved Europe late ‘14; US clinical trials to come

16 1/3/18

In Clinical Trials NuLens IOL (Dynacurve)

2-pc Accommodang IOL Out of the bag Sulcus-based 5.00D Accommodaon In Clinical Trials

CE Mark Oct. 2015; In Clinical Trials In Phase III Clinical Trials

• IOL powered by own power cell & computer chip embedded inside. Rechargeable & fully programmable, allowing adjustment of opcal power as visual needs change. Expect ~2018

Far vision- Near vision- Working on in situ customizaon via femtosecond laser to modify Source: Eyemaginaons/ELENZA refracve index of IOL

17 1/3/18

Topical Cataract Prevenon & Treatment?!?! Topical Cataract Prevenon & Treatment?!?!

• Drops to prevent/treat Drops to prevent Cataracts?!?! Cataracts?!?! • Unspecified... • Nanoparcles infused with • “Nonsurgical Cataract Treatment” Lutein • In conjuncon with UMASS • Rodent studies show • Protein aggregaon interceptor reducon in cataract size within 1 wk of tx

New & Emerging Ocular Technology

Presbyopia Reversal?

>1 Billion Presbyopes Worldwide

Presbyopia Reversal: Laser Ablaon of Cornea Presbyopia Reversal: Laser Ablaon of Cornea

PresbyLASIK • Mulfocal LASIK = advanced laser vision correcon to IIntracor change corneal shape & create diff. power zones for seeing varying distance • Just completed U.S. clinical trials (in other countries x several yrs) • Promising results?

Presbyond • Modified monovision correcon (dominant eye for distance, non-dominant eye with wavefront- No flap (enrely intrastromal); quick recovery; stable; opmized, slightly myopic ablaon) disadvantages: k stability, glare, loss of mesopic

18 1/3/18

Presbyopia (& Myopia) Reversal: Presbyopia (& Myopia) Reversal: Laser “Keratectomy” SMall Incision Lencule Extracon ReLEx SMILE: Uses Zeiss Visumax Femtosecond Laser

• FDA-approved September 2016 • >500K Procedures Worldwide since 2011 • Monovision or Distance Only Correcon • Create thin disc-shaped lencule within cornea which is then removed thru small, surface LASER incision

Presbyopia Reversal: Corneal Inlays Presbyopia Reversal: Corneal Inlays

• In general, inserted on Non-Dominant eye • Mechanisms: • Small Aperture Opcs (KAMRA) >1000 • Change Corneal Curvature (Raindrop) now done; • Change Index of Refracon (Flexivue Microlens, Icolens) Near VA • Techniques: stable 3 & • Lamellar (under LASIK flap) 5 years • Pocket post-op

Presbyopia Reversal: Corneal Inlays Presbyopia Reversal: Corneal Inlays

Flexivue Microlens (Presbia) = refracve inlay Raindrop Near Vision Inlay (ReVision Opcs) • Microscopic hydrogel inlay to correct presbyopia • Previously the Presbylens, then Vue+

Not yet FDA-approved but CE mark FDA Approval July 2016

19 1/3/18

Presbyopia Reversal: Corneal Inlays Presbyopia Reversal: Scleral Procedures

Mulfocal Refracve Inlay • Scleral Spacing Procedure; recently completed Phase III; results improved x me

Presbyopia Reversal: Scleral Procedures Presbyopia Reversal: Laser Ablaon of Lens

Lensar Laser Lens Soening • Uses Femtosecond Laser to soen lens nucleus • Trials underway with encouraging inial results?

Presbyopia Reversal: Pharmacologic Presbyopia Reversal: Pharmacologic

The Benozzi Method Liquid Vision (Presbyopia Therapies) • 1% Pilocarpine Parasympathec smulaon generates • Topical BID dosing & Reversible contracon & increased lens thickness = increased depth of • Short-term treatment for presbyopia focus (beer NVA, poorer DVA) • Miosis without accommodave spasm • + 0.1% Diclofenac • Clinical Trial Presbyopes in Mexico (avg age 51): Avg NVA = 20/22 Reduces intensity of pupillary & ciliary muscle contracons for • Phase II trials ’15 good vision @ all distances • 100 emmetrope study: DVA remained 20/20 with enhanced accommodaon/improved NVA x 5 yrs (only 4% pref. specs)

20 1/3/18

Presbyopia Reversal: Pharmacologic Presbyopia Reversal: Pharmacologic

Other formulaons in study, including: EVO6/Diopn? (Encore Vision) • Presbeyedrops

• 2 parasympathomimecs + 1 NSAID • Proposed mech. acon for Presbyopia = intracellular redox (lens • PresbyPlus proteins x-link = harden) • 2 Parasympathomimecs + 1 Parasympatholyc • Topical drop to “break” cross links & restore accommodaon • BID dosing x 30 days = ~ 2.0 D Accommodave Recovery • May 2016: Met Primary Safety & Efficacy Outcomes for Phase I-II • 75 paents b/t 45-55 yrs old with 20/20 BCDVA & worse than 20/40 DCNVA • Dosed BID • 1st Improvement @ Day 15, connuing thru the 90-Day Study Period

Second Skin

• Clear Siloxane cream spread over skin, then planum catalyst applied which transforms into cross-linked polymer layer • Result = invisible material Other Non-Tradional Therapeuc/Surgical Updates with very similar elasc properes to young skin

Corneal Collage Crosslinking (CXL) Corneal Collage Crosslinking (CXL) • Invented in Germany in 1998 to strengthen cornea (, • FDA-Approved April 18, 2016 post-LASIK ectasia, etc.) & prevent progression, not necessarily improve vision • Pre-tx topical anesthec & mild sedave (e.g. Valium); Epithelium prepped (may do epi-off or trans-epi/epi-on if thick enough K) • Vitamin B2 (riboflavin) g inslled & paent looks at UV Light • Outpaent procedure; OU Tx = 90 minutes; Monoc. Tx = 60 minutes • Now FDA-approved; pre-approval trial website (www.cxlusa.com) • Studies show: may prevent further vision loss in >98% of paents & improves vision in >50%; Epi-on beer than epi-off?; if performed with hyperopic LASIK, reduces regression?; also for advanced k-conus

21 1/3/18

Corneal Collage Crosslinking (CXL): Corneal Collage Crosslinking (CXL) Treatment of Myopia? • Clin Ophthalmol. 2014; 8: 697–702. • Published online 2014 Apr 7. doi: 10.2147/OPTH.S59934 • Therapy for microbial keras? • PMCID: PMC3984063 • Novel myopic refracve correcon with transepithelial very high- • Used in conjuncon with Orthokeratology? fluence collagen cross-linking applied in a customized paern: early clinical results of a feasibility study - Anastasios John Kanellopoulos • Can/should ODs do? • 4 cases; treated transepithelially in a myopic paern, total = 12 J/cm2 • Avg = 2.3 D myopic correcon achieved wk 1, with slight regression to 1.44 D @ 1 mo post-op (stable to 6 mo post-op) • Mean keratometry Δ = 44.90 D to 43.46 D, no signif Δ endothelial cell counts or k clarity; mild Δ epi thickness distribuon (mean = 8 μm)

TrueTear™: Intranasal Tear Neurosmulator?!?!.... LT-300 Photobiomodulator (LumiThera, Inc.)

• LIGHTSITE Study For Dry AMD Filed for FDA Approval • 42 eyes in 24 paents & Expected 4Q17 • 3-wk course of tx • LED light comprising red (670 nm), yellow (590 nm), & infrared (790 nm) applied to subjects’ eyes • Significantly improved , Contrast Sensivity, & Renal Drusen Volume • Improvements maintained x 3 mos

Not yet FDA-Approved

Surgical Glaucoma Updates Iray Radiotherapy System (Oraya) TUG (EyeSonix) • For Wet AMD • Therapeutic Ultrasound for Glaucoma  • Low power, low frequency x-rays voltage Low • • One me non-invasive treatment • Enhances outflow • Reduces # Intravitreal Injecons • In Clinical Trials Prelim: 20% IOP ê x 1 yr in 74% with elevated IOP

French co. Eye Tech Care developing same technology

22 1/3/18

New Glaucoma Theory/Therapy?

• SECO & ASCRS 2016 PAN-9086 (PanOpca) • John Berdahl, M.D.: Glaucoma not just an ocular condion, • Potent & selecve inhibitor of VEGF rather an imbalance between IOP & ICP • Preclinical trials completed by Wilmer Eye Instute at Johns Hopkins • His research revealed paents with glaucoma have lower ICP, (i.e. larger pressure gradient between IOP & ICP), producing • Completed Phase I/II Clinical Trials opc nerve damage • Effecve in 50% of treated individuals • Proposed Treatment: “Balance Goggles” manufactured by • Treatment of: Wet AMD, Diabec Renopathy & Equinox to equilibrate pressure across the opc nerve • It’s TOPICAL

Regenerave Medicine? BIIB033 (Biogen) Opna (Ampio Pharmaceucals) • Invesgaonal monoclonal anbody, administered intravenously • An-LINGO agent (LINGO-1 is a CNS-specific membrane • Ultra low-dose danazol (synthec derivave of testosterone) glycoprotein that suppresses oligodendrocyte differenaon & • Enhances endothelial cell barrier funcon for tx of DME myelinaon) • Early results: improved opc nerve latency in affected eye of acute • Oral opc neuris, as well as fellow eye • Large, late-stage clinical trials underway in U.S. • VEP latency improved post-tx, indicang remyelinaon • Poss. 1st true neuroprotecve agent for this? • IV administraon & now in Phase II

Regenerave Medicine? From Nature Neuroscience, 7/11/16: • Andrew Huberman & fellow Stanford researchers “...Help Mice With Technology in the Destroyed Opc Nerves To See Again” • Combined visual smulaon & viral acvaon of the mammalian target of Optometric Classroom? rapamycin (mTOR) led renal ganglion cells in blind mice to regenerate, restoring paral vision • In 70% of mice, axons regrew all the way to chiasm & “reconnected to their correct targets in the

23 1/3/18

Take Homes...

• Today’s success, does not guarantee tomorrow’s “People tell me, ‘You're such an opmist.’ Am I an opmist? An opmist says the glass is half full. • Sir Winston Churchill: A pessimist says the glass is half empty. “To improve is to change; to be perfect is to change oen.” A survivalist is praccal. He says, ‘Call it what you want, but just fill the glass.’ I believe in filling the glass.” - Louis Zamperini (subject of bestselling book & major moon picture Unbroken)

THANK YOU!!!

24